C-Reactive Protein Testing Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the c-reactive protein testing market size evolved in recent years?
There has been a consistent expansion in the market size for c-reactive protein testing over the past years. The market is projected to rise from a value of $3.45 billion in 2024 to $3.55 billion in 2025, with a compound annual growth rate (CAGR) of 2.9%. The previously observed growth in this domain can be credited to factors such as a surge in inflammatory disease incidents, cardiovascular risk evaluations, an increased elderly population, enhancement of healthcare infrastructure, and implementation of healthcare screening initiatives.
What are the predictions for the c-reactive protein testing market size in the coming years?
The market for c-reactive protein testing is projected to experience significant expansion in the upcoming years. The market is forecasted to reach $4.35 billion in 2029, growing at a compound annual growth rate (CAGR) of 5.2%. This growth during the forecasted period could be linked to factors such as increasing obesity rates, personalized medicine and biomarkers, telehealth and remote patient monitoring, early detection of diseases, and inflammation related to lifestyle. Key trends observed during the forecast period are advancements in diagnostic testing, adoption of wearable health technology, technological solutions, strategic partnerships, and the emergence of the industry 4.0.
Get your c-reactive protein testing market report here!
https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report
What key factors are fueling the growth of the c-reactive protein testing market?
The escalating prevalence of cardiovascular diseases, including heart-related conditions such as blood clots and diseased vessels, is projected to fuel the expansion of the c-reactive protein testing market. The exact origin of CVD remains unknown, but several aspects, including behavior-related risks such as poor diet, sedentary lifestyle, smoking, and alcohol consumption can amplify the propensity to contract it. These behavioural habits can lead to accumulation of fat deposits within the arteries, enhanced probability of blood clots, high blood pressure, blood sugar and lipid levels, weight increase and obesity. Given the rising incidence of cardiovascular diseases, there is a pressing demand for c-reactive protein testing to ascertain or predict cardiovascular complications as effectively as cholesterol level checks. For example, in December 2023, the Institute for Health Metrics and Evaluation revealed that world-wide fatalities from cardiovascular diseases touched 19.8 million in 2022, with ischemic heart disease being the primary contributor with 108.8 fatalities per 100,000 individuals. High systolic blood pressure was the chief contributor to life years adjusted for disability related to CVD, while factors like dietary risks and air pollution were the significant behavioural and environmental drivers exacerbating this global issue.
How is the global c-reactive protein testing market divided into key segments?
The c-reactive protein testing market covered in this report is segmented –
1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays
2) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications
3) By End Use: Clinics, Hospitals, Diagnostic Laboratories
Subsegments:
1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA
2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA, Automated CLIA Systems
3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays, Latex Agglutination Immunoturbidimetric Assays
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6719&type=smp
Who are the key firms paving the way for growth in the c-reactive protein testing market?
Major companies operating in the c-reactive protein testing market include Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMérieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation
Which trends are expected to transform the c-reactive protein testing market?
One significant trend observed in the c-reactive protein testing market is the surging innovations in measurement technology. To maintain and enhance their market dominance, primary players in this market are concentrating on the delivery of technologically sophisticated solutions. Such businesses have been integrating advanced c-reactive testing technologies into their testing procedures and devising enhanced solutions that offer maximum performance and multifunctionality. For instance, in February 2022, Aidian, a company based in Finland that specializes in diagnostic tests and test solutions, launched the QuikRead go wrCRP & wrCRP+Hb kits. These kits deliver dual results from one analysis of a single sample, encompassing a broad CRP and Hb range. The wide-range CRP test facilitates CRP measurement to analyze conditions such as neonatal sepsis, foretell the severity of COPD (chronic obstructive pulmonary disease), and contribute to cardiovascular risk evaluation.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6719
What regions are contributing significantly to the growth of the c-reactive protein testing market?
North America was the largest region in the c-reactive protein testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Protein Expression Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report
Oral Biologics & Biosimilar Drugs Global Market Report 2024
Protein Labeling Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/protein-labelings-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
